Zinc levels in children with community-acquired pneumonia: a comparative study in the context of SARS-CoV-2 infection
DOI:
https://doi.org/10.15574/SP.2024.8(144).3033Keywords:
community-acquired pneumonia, zinc, children, trace elementAbstract
It has been proven that a deficiency of zinc, can significantly weaken the body's immune response to infection. Zinc plays a key role in many immunological processes, such as the proliferation and differentiation of lymphocytes, antibody synthesis, and phagocytosis.
Aim: to assess the dynamics of zinc levels in pediatric patients with community-acquired pneumonia, taking into account the presence or absence of SARS-CoV-2 co-infection in the acute phase of the disease and the recovery period.
Materials and methods. The study included 114 children aged 6 to 18 years. The Basic group consisted of 81 patients diagnosed with community-acquired pneumonia, divided into subgroups based on the presence or absence of SARS-CoV-2 co-infection. The Control group consisted of 33 healthy children matched by age and gender. Zinc levels in serum were determined for all children. The results of the study were processed using Microsoft Excel 2013.
Results. All children in the Basic group had decreased serum zinc levels in both the acute phase and convalescent periods. Children with severe community-acquired pneumonia, regardless of viral infection, showed only a slight increase in zinc levels with standard treatment. A significant decrease in serum zinc levels was found in all children with pneumonia compared to the Control group. Patients with SARS-CoV-2 demonstrated a more pronounced zinc deficiency compared to those with pneumonia of other etiologies. During treatment, a gradual increase in zinc levels was observed in all patient groups.
Conclusions. The study revealed a decrease in zinc concentration in children with community-acquired pneumonia, both during the acute phase and during the convalescent period of the disease. Patients with SARS-CoV-2 infection had significantly lower zinc levels compared to children without detected coronavirus.
The study was carried out in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Ethical Committee for all participants in the process. The informed consent was obtained from children and parents for participation.
No conflict of interests was declared by the authors.
References
Arigliani M, Spinelli AM, Liguoro I, Cogo P. (2018). Nutrition and Lung Growth. Nutrients. 10(7): 919. https://doi.org/10.3390/nu10070919; PMid:30021997 PMCid:PMC6073340
Finzi E. (2020). Treatment of SARS-CoV-2 with high dose oral zinc salts: a report on four patients. Int J Infect Dis: IJID: Off Publ Int Soc Infect Dis. 99: 307-309. https://doi.org/10.1016/j.ijid.2020.06.006; PMid:32522597 PMCid:PMC7834648
Gammoh NZ, Rink L. (2017). Zinc in Infection and Inflammation. Nutrients. 9(6): 624. https://doi.org/10.3390/nu9060624; PMid:28629136 PMCid:PMC5490603
Ghanei E, Baghani M, Moravvej H, Talebi A, Bahmanjahromi A, Abdollahimajd F. (2022). Low serum levels of zinc and 25-hydroxyvitmain D as potential risk factors for COVID-19 susceptibility: a pilot case-control study. European journal of clinical nutrition. 76: 1297-1302. https://doi.org/10.1038/s41430-022-01095-5; PMid:35322170 PMCid:PMC8941827
Gombart AF, Pierre A, Maggini S. (2020). A Review of Micronutrients and the Immune System-Working in Harmony to Reduce the Risk of Infection. Nutrients. 12(1): 236. https://doi.org/10.3390/nu12010236; PMid:31963293 PMCid:PMC7019735
Guido Cereda et al. (2022). Zinc as a Neuroprotective Nutrient for COVID-19 - Related Neuropsychiatric Manifestations: A Literature Review, Advances in Nutrition. 13(1): 66-79. https://doi.org/10.1093/advances/nmab110; PMid:34634109 PMCid:PMC8524565
Heller RA, Sun Q, Hackler J, Seelig J, Seibert L, Cherkezov A et al. (2021). Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker. Redox Biol. 38: 101764. https://doi.org/10.1016/j.redox.2020.101764; PMid:33126054 PMCid:PMC7574778
Hu T, Sarpong EM, Song Y, Done N, Liu Q, Lemus-Wirtz E et al. (2023). Incidence of non-invasive all-cause pneumonia in children in the United States before and after the introduction of pneumococcal conjugate vaccines: a retrospective claims database analysis. Pneumonia (Nathan). 15(1): 8. https://doi.org/10.1186/s41479-023-00109-5; PMid:37016411 PMCid:PMC10074783
Institute of Health Metrics and Evaluation. (2019). Global Burden of Disease Study, 2019. URL: http://ghdx.healthdata.org/gbd-2019.
Kevat PM, Morpeth M, Graham H, Gray AZ. (2022). A systematic review of the clinical features of pneumonia in children aged 5-9 years: Implications for guidelines and research. J Glob Health. 12: 10002. https://doi.org/10.7189/jogh.12.10002; PMid:35356655 PMCid:PMC8943783
Kirolos A, Blacow RM, Parajuli A, Welton NJ, Khanna A, Allen SJ et al. (2021). The impact of childhood malnutrition on mortality from pneumonia: a systematic review and network meta-analysis. BMJ Glob Health. 6(11) :e007411. https://doi.org/10.1136/bmjgh-2021-007411; PMid:34848440 PMCid:PMC8634228
Knebusch N, Mansour M, Vazquez S, Coss-Bu JA. (2023). Macronutrient and Micronutrient Intake in Children with Lung Disease. Nutrients. 15(19): 4142. https://doi.org/10.3390/nu15194142; PMid:37836425 PMCid:PMC10574027
Kramarov S, Yevtushenko V, Yevtushenko O. (2021). The value of zinc in infectious diseases in children. Actual Infectology. 8(1): 17-24. https://doi.org/10.22141/2312-413x.8.1.2020.196167
Luan R, Ding D, Xue Q et al. (2023). Protective role of zinc in the pathogenesis of respiratory diseases. Eur J Clin Nutr. 77: 427-435. https://doi.org/10.1038/s41430-022-01191-6; PMid:35982216 PMCid:PMC9387421
Pechugina VV, Usachova OV. (2023). Modern ideas about the importance of providing zinc in infectious diseases in children. Modern Pediatrics. Ukraine. 3(131): 97-103. https://doi.org/10.15574/SP.2023.131.97
Popovsky EY, Florin TA. (2022). Community-Acquired Pneumonia in Childhood. Encyclopedia of Respiratory Medicine. 6: 119-131. https://doi.org/10.1016/B978-0-08-102723-3.00013-5; PMCid:PMC7458534
Sakulchit T, Goldman RD. (2017). Zinc supplementation for pediatric pneumonia. Can Fam Physician. 63(10): 763-765. PMID: 29025801; PMCID: PMC5638472.
Skalny AV et al. (2020). Zinc and respiratory tract infections: Perspectives for COVID-19 (Review). International journal of molecular medicine. 46(1): 17-26. https://doi.org/10.3892/ijmm.2020.4575; PMid:32319538 PMCid:PMC7255455
United Nations International Children's Emergency Fund. (2023). Pneumonia in children: Everything you need to know. URL: https://www.unicef.org/stories/childhood-pneumonia-explained.
Volosovets O, Bolbot Y, Abaturov O, Kryvopustov S, Besh L, Stoieva T et al. (2020). Dynamics of the incidence rate of pneumonia in children in Ukraine over the past 20 years. Med. perspekt. 25(4): 174-181. URL: https://journals.uran.ua/index.php/2307-0404/article/view/221680. https://doi.org/10.26641/2307-0404.2020.4.221680
Wessels I, Pupke JT, von Trotha KT, Gombert A, Himmelsbach A, Fischer HJ et al. (2020). Zinc supplementation ameliorates lung injury by reducing neutrophil recruitment and activity. Thorax. 75(3): 253-261. https://doi.org/10.1136/thoraxjnl-2019-213357; PMid:31915307
World Health Organization. (2022). Pneumonia in children. Geneva. URL: https://www.who.int/news-room/fact-sheets/detail/pneumonia.
Yang M, Li Y, Yao C, Wang Y, Yan C. (2023). Association between serum copper-zinc ratio and respiratory tract infection in children and adolescents. PLoS ONE. 18(11): e0293836. https://doi.org/10.1371/journal.pone.0293836; PMid:37917592 PMCid:PMC10621854
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
